Minimally invasive surgery (MIS) allows doctors to perform many complicated operations with a short hospital stay. It is a safe, feasible, and patient-friendly method of performing an operation. In addition, MIS has been shown to reduce hospital-acquired infections.

This report includes product information, procedure volume data, world demographics, and other general issues affecting the MIS device market. Information is presented as a worldwide overview, with a focus on the US. A market summary includes market analysis by intended use and a competitive analysis of leading providers.

The following companies are profiled in this report:

• Aesculap Division
• ArthroCare Inc
• Boston Scientific Corporation
• Conmed Corporation
• Covidien Ltd
• Given Imaging, Ltd.
• Innovative Surgical Inc.
• Johnson & Johnson, Inc
• Karl Storz GmbH & Co. KG
• Medtronic, Inc
• Olympus Corporation
• Smith & Nephew, Plc
• Stryker Corporation

The report provides total market sizes in six general surgery areas reflecting revenues earned by all manufacturers in all MIS methods in those areas. Revenues for each therapeutic area were gathered through both primary and secondary research methods. General surgery areas include:

• Orthopedic MIS Device Market (included in total market size number in this report are arthoscopes, autoclavable laoparoscope, holmium lasers, other devices)
• Neurosurgery MIS Device Market (included in total market size number in this report are neuroendoscopes, bronchoscope, esophoscope, others)
• ENT/Respiratory MIS Device Market (included in total market size number in this report are laryngoscopes, ventriculoscopes, contact lasers, others)
• Cardiovascular MIS Device Market (included in total market size figure are laparoscopes, ablation systems, endoscopes, others)
• Gastrointestinal System MIS Device Market (included in total market size figure are endoscopes, sigmoidoscopes, videoscopes, others)
• Urological and Gynecological MIS Device Market (included in total market size figure are hysteroscopes, cystoscopes, others)

The purpose of this report is to provide an understanding of the total current market for all MIS methods for each therapeutic area. In the scope of this report they are considered as competitive methods and are not broken down to specific device segments (for instance 'Gastroinestinal System Devices' will contain a number for all competing MIS methods in GI, but will not have a specific sigmoidoscope or GI endoscope number).

As this is a global survey, revenues and a five year forecast are provided for the following regions:

• US
• Europe
• Rest of World

Procedure volumes are available for the following surgeries for which minimally invasive equipment is utilized:

• Hip Replacement, Pinning, etc.
• Knee Repair/Fixation, Procedures
• Spinal Fusion/Spinal Hardware Removal
• Shoulder Repair/Fixation
• Lumbar Laminectomy/ Thoracic-lumbar
• Laminectomy/Diskectomy and Lumbar Decompression and Fusion
• Craniotomy (all types)
• Ventricular-Peritoneal Shunt Insertion/ Removal/Revision
• Detether Cord (adult and pediatric)
• Ethmoidectomy
• Tonsillectomy
• Thyroidectomy
• Coronary Revascularization
• Aortic Valve Replacement or Repair
• Cardiac Catheterization
• Insertion of Coronary Artery Stent(s)
• Appendectomy
• Endoscopy with or without biopsy
• Cholecystectomy
• Inguinal Herniorrhaphy
• Hysterectomy (all types)
• Prostatectomy

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 45 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives:

All market data pertains to the world market at the manufacturers' level. The base year for data was 2010. Compound annual growth rates (CAGRs) are provided for each region and/or segment covered. Competitive analysis is provided for the year 2010. The forecasted market analysis for was largely based on demographic trends, new developments, and global expansion.

All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that we be utilized by more than one user at your company. Please consult ask your sales representative or select the correct license on our website.

For Kalorama's take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information's Key Point Blog at http://kaloramakeypoint.blogspot.com/

Additional Information

New York, NY, May 11, 2011-Data that shows minimally invasive surgery (MIS) procedures may reduce hospital-acquired infections will give an additional boost to the $24.8 billion market for MIS equipment, according to healthcare market research firm Kalorama Information. Kalorama estimates this market will reach $34.8 billion by 2015 in its latest report, Minimally Invasive Surgical Devices, World Market.

Minimally invasive surgery, which uses specialized instruments, miniature cameras with microscopes, tiny fiber-optic flashlights and high definition monitors, makes an incision about 2 to 4 inches in length, which is much smaller than the traditional 6 to 10 inches. The report cites recent survey data which found that using this method results in less trauma to the body, less blood loss, smaller surgical scars, a lower risk of contracting a hospital-acquired infection and shorter hospital stays.

"It's a win-win for government and insurance companies looking to reduce long-term healthcare costs," says Bruce Carlson, publisher of Kalorama Information. "Although the devices are expensive, the cost is justified by long-term savings and more effective patient treatment."

According to the report, 40% of hospital-acquired infections from hysterectomy, appendectomy and laparoscopic cholecystectomy occurred within 30 days after hospital discharge. However, the use of MIS saw an overall decrease in the odds of acquiring an infection, specifically an 80% reduction in respiratory tract infections, a 69% reduction in bloodstream infections, a 59% reduction in wound infections and a 39% reduction in urinary tract infections.

"Reducing hospital-acquired infections translates to a reduction in readmissions to the hospital, patient suffering and cost," adds Carlson. "The key factor in the use of these devices is keeping patients in the hospital for the least amount of time."

Minimally Invasive Surgical Devices, World Market includes product information, procedure volume data, world demographics and trends, as well as detailed company profiles. Total market sizes for six general surgery areas, reflecting revenue earned by manufacturers, are broken up by U.S., Europe and Rest of World.

Related Reports:

The Worldwide Market for In Vitro Diagnostic Tests, 8th Edition (pre-publication)
Jul 20, 2012 - KLI3811539 - $6,500.00

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
May 11, 2012 - KLI3889488 - $3,995.00

The Global Market for Medical Devices, 3rd. Edition
May 2, 2012 - KLI3873247 - $2,500.00

White Paper: Why Hospitals are Choosing Handhelds
Apr 19, 2012 - KLI3866251 - $0.00

The World Anesthesia Drug Market (General, Local, Adjunctive)
Mar 22, 2012 - KLI3811533 - $3,995.00

EMR 2012: The Market for Electronic Medical Records
Mar 13, 2012 - KLI3804306 - $3,500.00

IVD Market Research Bundle (In Vitro Diagnostic Test Markets, BRIC and Other Regional Markets, Biomarker Testing and Other Pharmacodiagnostics)
Mar 3, 2012 - KLI2401913 - $5,995.00

World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
Mar 1, 2012 - KLI6801442 - $3,995.00

World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)
Feb 1, 2012 - KLI6772957 - $3,800.00

Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)
Jan 1, 2012 - KLI6490034 - $3,995.00